Laura E. Happe

1.3k total citations
42 papers, 849 citations indexed

About

Laura E. Happe is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Laura E. Happe has authored 42 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 10 papers in Cardiology and Cardiovascular Medicine and 10 papers in Internal Medicine. Recurrent topics in Laura E. Happe's work include Health Systems, Economic Evaluations, Quality of Life (14 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Laura E. Happe is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (14 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Laura E. Happe collaborates with scholars based in United States, France and Jordan. Laura E. Happe's co-authors include Orsolya Lunacsek, Gary S. Marshall, Charles R. Woods, Sebastian Schneeweiß, Shirley Wang, Michael D. Szymanski, Matthew Zahn, Wim Goettsch, Jeffrey S. Brown and Kenneth J. Rothman and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and CHEST Journal.

In The Last Decade

Laura E. Happe

36 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura E. Happe United States 14 237 146 133 126 124 42 849
Sudeep Karve United States 20 321 1.4× 24 0.2× 42 0.3× 203 1.6× 82 0.7× 63 1.5k
Adriana López‐Pineda Spain 18 178 0.8× 27 0.2× 93 0.7× 198 1.6× 122 1.0× 87 1.0k
Stan Xu United States 16 217 0.9× 293 2.0× 41 0.3× 133 1.1× 159 1.3× 28 1.3k
Jérôme Drouin France 20 149 0.6× 84 0.6× 15 0.1× 165 1.3× 62 0.5× 53 1.1k
Sylvia Robles United States 20 903 3.8× 103 0.7× 61 0.5× 120 1.0× 316 2.5× 35 2.0k
Martin Siegel Germany 15 162 0.7× 102 0.7× 123 0.9× 20 0.2× 114 0.9× 33 549
Nandini Selvam United States 16 99 0.4× 47 0.3× 14 0.1× 89 0.7× 56 0.5× 38 736
Stefano Capri Italy 17 189 0.8× 65 0.4× 18 0.1× 43 0.3× 74 0.6× 67 938
Jo‐Anne Manski‐Nankervis Australia 20 239 1.0× 141 1.0× 13 0.1× 51 0.4× 307 2.5× 101 1.2k
Cam Solomon United States 17 272 1.1× 357 2.4× 10 0.1× 117 0.9× 327 2.6× 26 1.7k

Countries citing papers authored by Laura E. Happe

Since Specialization
Citations

This map shows the geographic impact of Laura E. Happe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Happe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Happe more than expected).

Fields of papers citing papers by Laura E. Happe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Happe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Happe. The network helps show where Laura E. Happe may publish in the future.

Co-authorship network of co-authors of Laura E. Happe

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Happe. A scholar is included among the top collaborators of Laura E. Happe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Happe. Laura E. Happe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mattingly, T. Joseph, et al.. (2025). Emerging trends in managed care pharmacy: A mixed-method study. Journal of Managed Care & Specialty Pharmacy. 31(2-a Suppl). S2–S10.
2.
Essien, Utibe R., et al.. (2025). Pharmacoequity measurement framework: A tool to reduce health disparities. Journal of Managed Care & Specialty Pharmacy. 31(2). 214–224.
3.
Happe, Laura E., et al.. (2024). Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year period. Journal of Managed Care & Specialty Pharmacy. 30(12). 1355–1363.
4.
Happe, Laura E., et al.. (2023). A primer on managed care pharmacy. Journal of Managed Care & Specialty Pharmacy. 29(12). 1371–1376. 2 indexed citations
5.
Happe, Laura E.. (2020). Distinguishing Predatory from Reputable Publishing Practices. Journal of Managed Care & Specialty Pharmacy. 26(8). 956–960. 14 indexed citations
6.
Cordier, Tristan, et al.. (2019). Primary Care Provider Encounter Cadence and HbA1c Control in Older Patients With Diabetes. American Journal of Preventive Medicine. 57(4). e95–e101. 9 indexed citations
8.
Castro, Cynthia M., et al.. (2017). Outcomes of a Digital Health Program With Human Coaching for Diabetes Risk Reduction in a Medicare Population. Journal of Aging and Health. 30(5). 692–710. 98 indexed citations
10.
Happe, Laura E., et al.. (2014). Frequency and Economic Impact of Comorbid Cardiac Conditions with Multiple Sclerosis. Journal of Managed Care Pharmacy. 20(8). 795–799. 5 indexed citations
11.
Happe, Laura E., et al.. (2013). Using Grey Literature to Prepare Pharmacy Students for an Evolving Healthcare Delivery System. American Journal of Pharmaceutical Education. 77(4). 82–82. 2 indexed citations
13.
Happe, Laura E., Orsolya Lunacsek, Denise Kruzikas, & Gary S. Marshall. (2009). Impact of a Pentavalent Combination Vaccine on Immunization Timeliness in a State Medicaid Population. The Pediatric Infectious Disease Journal. 28(2). 98–101. 34 indexed citations
14.
Null, Donald M., et al.. (2008). THE ECONOMIC BURDEN OF BRONCHOPULMONARY DYSPLASIA DURING THE FIRST TWO YEARS OF LIFE. Archives of Disease in Childhood. 93. 1 indexed citations
15.
Kwong, Louis M., Laura E. Happe, Ruslan Horblyuk, & Eileen Farrelly. (2008). Decreased Venous Thromboembolism with Injectable Vs Oral Anticoagulation After Discharge for Major Orthopedic Surgery. The Journal of Arthroplasty. 23(6). 25–30. 7 indexed citations
16.
Happe, Laura E., et al.. (2008). Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants. Current Medical Research and Opinion. 25(2). 413–420. 17 indexed citations
17.
Nutescu, Edith A., et al.. (2008). Burden of Deep Vein Thrombosis in the Outpatient Setting Following Major Orthopedic Surgery. Annals of Pharmacotherapy. 42(9). 1216–1221. 13 indexed citations
18.
Happe, Laura E., et al.. (2007). Combination vaccine use and vaccination quality in a managed care population.. PubMed. 13(9). 506–12. 41 indexed citations
19.
Shorr, Andrew F., Louis M. Kwong, Matthew Sarnes, et al.. (2007). Venous thromboembolism after orthopedic surgery: Implications of the choice for prophylaxis. Thrombosis Research. 121(1). 17–24. 25 indexed citations
20.
Happe, Laura E., et al.. (2007). Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries. Journal of Thrombosis and Thrombolysis. 26(2). 125–131. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026